# Paul Polakis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-polakis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,728 |
| Field | Wnt/β-catenin signaling in development and cancer |
| h-index | 71 |
| i10-index | 118 |
| Last Known Institution | Intarcia Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5059337835 |
| Works | 244 |

## Researcher topics

- [Wnt/β-catenin signaling in development and cancer](https://scholariq.org/topics/wnt-catenin-signaling-in-development-and-cancer-2/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer-related gene regulation](https://scholariq.org/topics/cancer-related-gene-regulation/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Researcher university

- [Intarcia Therapeutics (United States)](https://scholariq.org/institutions/intarcia-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.